Cargando…

Peripheral immune markers and antipsychotic non-response in psychosis

BACKGROUND: Peripheral immune markers have previously been linked to a poor response to antipsychotic medication and more severe negative symptoms at the onset of psychosis. The present study investigated the association of blood cytokines and complement markers with the presence of antipsychotic no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enache, Daniela, Nikkheslat, Naghmeh, Fathalla, Dina, Morgan, B. Paul, Lewis, Shôn, Drake, Richard, Deakin, Bill, Walters, James, Lawrie, Stephen M., Egerton, Alice, MacCabe, James H., Mondelli, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Publisher B. V 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224180/ https://www.ncbi.nlm.nih.gov/pubmed/33667853 http://dx.doi.org/10.1016/j.schres.2020.12.020

Ejemplares similares

Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration
por: Egerton, Alice, et al.
Publicado: (2022)

Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)
por: Egerton, Alice, et al.
Publicado: (2020)

Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
por: Millgate, Edward, et al.
Publicado: (2021)

M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Griffiths, Kira, et al.
Publicado: (2020)

Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA study
por: Griffiths, Kira, et al.
Publicado: (2022)

The relationship between nicotine and psychosis
por: Quigley, Harriet, et al.
Publicado: (2019)

Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
por: Kopra, Emma, et al.
Publicado: (2021)

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
por: Merritt, Kate, et al.
Publicado: (2019)

Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure
por: Downs, Johnny, et al.
Publicado: (2019)

The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial
por: Deakin, Bill, et al.
Publicado: (2018)

Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study
por: Millgate, Edward, et al.
Publicado: (2022)

Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
por: Gillespie, Amy L., et al.
Publicado: (2017)

Does tobacco use cause psychosis? Systematic review and meta-analysis
por: Gurillo, Pedro, et al.
Publicado: (2015)

Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers
por: Watson, Andrew J., et al.
Publicado: (2023)

Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland
por: Ingimarsson, Oddur, et al.
Publicado: (2016)

T86. COGNITIVE SUBTYPES IN FIRST-EPISODE PSYCHOSIS: AN EMPIRICAL LONGITUDINAL STUDY OF RELATIONSHIP TO COGNITIVE, SYMPTOM AND FUNCTIONAL OUTCOMES
por: Watson, Andrew, et al.
Publicado: (2018)

S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Sendt, Kyra-Verena, et al.
Publicado: (2018)

It is time to start taking tobacco seriously as a risk factor for psychosis: self‐medication cannot explain the association
por: MacCabe, J. H.
Publicado: (2018)

Antipsychotic polypharmacy prescribing and risk of hospital readmission
por: Kadra, Giouliana, et al.
Publicado: (2017)

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
por: Jauhar, Sameer, et al.
Publicado: (2023)

The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study
por: Jauhar, Sameer, et al.
Publicado: (2019)

Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis
por: Pollak, Thomas A., et al.
Publicado: (2021)

Biological Predictors of Clozapine Response: A Systematic Review
por: Samanaite, Ruta, et al.
Publicado: (2018)

Using quantitative MRI to study brain responses to immune challenge with interferon-α
por: Nettis, Maria Antonietta, et al.
Publicado: (2021)

Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study
por: Ajnakina, Olesya, et al.
Publicado: (2017)

The influence of comorbid depression and overweight status on peripheral inflammation and cortisol levels
por: McLaughlin, Anna P., et al.
Publicado: (2022)

Predictors of long-term (≥ 6 months) antipsychotic polypharmacy prescribing in secondary mental healthcare
por: Kadra, Giouliana, et al.
Publicado: (2016)

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
por: Nettis, Maria Antonietta, et al.
Publicado: (2021)

Second Generation Antipsychotics Improve Sexual Dysfunction in Schizophrenia: A Randomised Controlled Trial
por: Mahmoud, Ahmed, et al.
Publicado: (2011)

Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Nikkheslat, Naghmeh
Publicado: (2021)

Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis
por: Beck, Katherine, et al.
Publicado: (2015)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021)

Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis
por: Pistis, Giorgio, et al.
Publicado: (2022)

The temporal dynamics of sleep disturbance and psychopathology in psychosis: a digital sampling study
por: Meyer, Nicholas, et al.
Publicado: (2022)

The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
por: Kose, Melisa, et al.
Publicado: (2021)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine
por: Govind, Risha, et al.
Publicado: (2022)

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
por: Merritt, Kate, et al.
Publicado: (2013)

Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study
por: Casetta, Cecilia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gbi0060llm2mfse5epk6jg14a7